dc.creator | Solórzano Peck, Guillermo | |
dc.creator | Briceño, Javier | |
dc.creator | Padillo Ruiz, Francisco Javier | |
dc.creator | Díaz Iglesias, Carlos | |
dc.creator | Marchal Molina, Trinidad | |
dc.creator | Rufián Peña, Sebastián | |
dc.creator | Mata García, Manuel de la | |
dc.creator | Barrera Baena, Pilar | |
dc.creator | López Cillero, Pedro | |
dc.creator | Pozo Laderas, Juan Carlos | |
dc.creator | Montero Álvarez, J. L. | |
dc.creator | Costán Rodero, Guadalupe | |
dc.creator | Fraga Rivas, Enrique | |
dc.creator | López Vallejos, P. | |
dc.creator | Pérez de Luque, Daniel | |
dc.date.accessioned | 2015-02-04T20:52:13Z | |
dc.date.available | 2015-02-04T20:52:13Z | |
dc.date.issued | 2006 | |
dc.identifier.issn | 1130-0108 | es |
dc.identifier.uri | http://hdl.handle.net/11441/18261 | |
dc.description.abstract | Objective: the goal of this research has been to evaluate the
survival, in long and short term, of the patient receiving liver
transplant for hepatocellular carcinoma (HCC), the risk of posttransplant
tumor relapse and factors related to this complication.
Design: retrospective study of a consecutive series of patients
having had liver transplant for HCC.
Patients and methodology: transplant patients for HCC from
1989 to November 2003. Patients were selected due to general limitations
of nodule size and quantity, which were subsequently published
as Milan criteria. Also, criteria agreed in the Conference of
Barcelona were followed in the pre-transplant diagnosis.
Results: the survival of this 81 patients group was of the 80,
61 and 52% for 1, 5 and 10 years respectively. In the 32% of the
cases the HCC was an incidental finding in the explant. In the
12.3%, the tumor relapse was verified. The multivariate research
identified the size of the nodule (OR = 1,7944) (IC 95% =
1,1332-2,8413) and the vascular invasion (OR = 6,6346) (IC
95% = 1,4624-30,1003) as risk factors of relapse.
Conclusions: the liver transplant in selected patients with HCC
has good results in medium and long term. The risk of post-transplant
tumor relapse becomes notably reduced and is associated with
the size of the nodule and the microscopic vascular invasion. | es |
dc.language.iso | eng | es |
dc.relation.ispartof | Revista Española de Enfermedades Digestivas, 98 (12), 899-906. | es |
dc.rights | Atribución-NoComercial-SinDerivadas 4.0 España | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Hepatocellular carcinoma | es |
dc.subject | liver transplant | es |
dc.subject | incidental tumors | es |
dc.subject | survival | es |
dc.title | Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Cirugía | es |
dc.journaltitle | Revista Española de Enfermedades Digestivas | es |
dc.publication.volumen | 98 | es |
dc.publication.issue | 12 | es |
dc.publication.initialPage | 899 | es |
dc.publication.endPage | 906 | es |
dc.identifier.idus | https://idus.us.es/xmlui/handle/11441/18261 | |